Results - Announcements
NGL Fine Chem Ltd share price declined by 1.99% to Rs 2809.65 after the company's net profit dropped 11.68% to Rs 16.25 crore, while revenue from operations increased 14.05% to Rs 158.71 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, rising 5.54%. It has marginally improved by 2.89% over last one week and moved up slightly by 3.43% in last one month while the market capitalization of NGL Fine Chem Ltd has edged up by 10.14% and 18.07% in the same period respectively.
Profit before tax (PBT) of NGL Fine Chem Ltd stood at Rs 21.6 crore in Q2 FY27, rallying 66.67% year-on-year, and dropping 11.76% quarter-on-quarter. EBITDA came in at Rs 27 crore, jumping 77.76% YoY and surging by 69.46% sequentially.
Total expenses increased by 13.26% to Rs 137.19 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 86.77 crore, growing marginally by 7.83% YoY, while employee benefits expense was at Rs 21.19 crore, witnessing a strong rise of 12% YoY.
For FY26, revenue from operations witnessed a strong growth of 36.03% to Rs 500.95 crore, while net profit surged by 127.89% to Rs 48.13 crore, compared to previous FY. EBITDA jumped by 3137% to Rs 57.96 crore, and PBT surged 128.69% to Rs 63.37 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 43.32 crore in FY26, as against Rs 32.36 crore in FY25.
NGL Fine Chem Ltd soared by 92.31% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.74% during the same period.